• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Medical Device Problem Codes Material Frayed (1262); Difficult to Remove (1528); Physical Resistance/Sticking (4012)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/22/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event or Problem Description
It was reported that an versacross access solution was selected watchman procedure.During insertion, the access was granted, and it was being tried to go up with the mechanical guidewire.However, the guidewire got stripped and stuck upon tentative to remove it from the dilator hub.Once the guidewire was removed, it was noted to be unraveling, it was fully retrieved from the patient anatomy, and it remained in one piece.Thus, a new versacross connect kit was opened, and the procedure was completed successfully.No patient complication was reported.The device is not returning for analysis as it was discarded in facility.
 
Event or Problem Description
It was reported that an versacross access solution was selected watchman procedure.During insertion, the access was granted, and it was being tried to go up with the mechanical guidewire.However, the guidewire got stripped and stuck upon tentative to remove it from the dilator hub.Once the guidewire was removed, it was noted to be unraveling, it was fully retrieved from the patient anatomy, and it remained in one piece.Thus, a new versacross connect kit was opened, and the procedure was completed successfully.No patient complication was reported.The device is not returning for analysis as it was discarded in facility.
 
Additional Manufacturer Narrative
The device was not returned for analysis.However, based on the media provided, the reported allegation was confirmed.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Common Device Name
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
angela hinkley
4100 hamline avenue north
dc a330
saint paul, MN 55112
6514400979
MDR Report Key20194665
Report Number2124215-2024-56864
Device Sequence Number7535506
Product Code DRE
UDI-Device Identifier00685447012573
UDI-Public00685447012573
Combination Product (Y/N)N
Initial Reporter StateNC
Initial Reporter CountryUS
PMA/510(K) Number
K220414
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/22/2024
Supplement Date Received by Manufacturer09/24/2024
Initial Report FDA Received Date09/11/2024
Supplement Report FDA Received Date10/04/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Unknown
Patient Sequence Number1
Patient SexUnknown
-
-